We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Healthcare groups call for reforms to pharma supply chains as up to half a million patients could be affected
Nobel Prize winner who discovered the cause of cervical cancer in humans
Isle of Man’s GLO wants to sell 25 per cent to clients, letting them influence production
Error prompts life assurance customers to pause or review relationship with early detection biotech
Marketing attractive nicotine products to children risks a whole generation’s health
Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans
The leaked draft of the WHO Pandemic Accord contains worrying signs
Policy prescriptions are plentiful but momentum and money behind them is lacking
Is this legal manoeuvre setting a precedent for corporations to evade accountability in America?
Health official’s admission undermines Beijing’s dismissals that virus could have emerged from Wuhan facility
Rise in temperatures has led to the spread of disease-carriers to higher altitudes
Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes
Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing
As McDonald’s is targeted, governments also need to tighten and enforce rules
Neurotechnology restores natural gait with device that decodes brain’s signals for people with spinal injuries
The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain
The organ recovery technique has provoked criticism from within the scientific community
Human life appears to have an upper limit that has yet to be extended
Investors are pouring billions into companies claiming they can analyse DNA to find the disease early. But some scientists question if they really work
Our craving for human company causes psychological stress, which induces physiological effects
Mental health has deteriorated since 2019 with young impacted most, data shows
Alzheimer’s advocates call for ambitious declaration to match the scope of commitments made 10 years ago
US biotech group is among coronavirus vaccine makers struggling with reduced demand post-pandemic
Shadow health secretary sets out plan to boost clinical research
From India to Britain, we have always managed to get in the way of our own inventiveness
International Edition
